
Dashori 20mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Dasatinib (20mg)
Overview Dashori 20mg Tablet
Leukemia treatment with Dasho 20mg tablets targets chronic myeloid leukemia. Prescribed for patients unresponsive to or intolerant of alternative leukemia therapies, this medication may be taken with or without food, consistently at the same time daily for optimal results. Dosage and frequency are determined by your physician based on your condition and may adjust over time; strictly adhere to prescribed instructions. Incorrect usage or overdose may result in severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's direction. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) are possible and warrant immediate medical attention. Regular blood pressure monitoring may be necessary. Avoid antacids within two hours of ingestion. Reduced blood cell counts increase infection risk, necessitating regular blood tests. Inform your healthcare provider about all medications you're taking, as interactions are possible. Use during pregnancy or breastfeeding is discouraged. Refrain from driving if dizziness or visual disturbances occur.
Primary Ingredients of Dashori 20mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Dashori 20mg Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Dashori 20mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Dashori 20mg Tablets can be consumed with or without food, however, consistency in the time of administration is recommended.
Common Side effects of Dashori 20mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dashori 20mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 20mg Dashori Tablet whole; do not break, crush, or chew it. While it can be taken with or without food, consistency is key—take it at the same time each day.
How Dashori 20mg Tablet works:
Oncaspar 20mg tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a mutated protein responsible for triggering uncontrolled cancer cell proliferation. This effect contributes to the retardation or cessation of tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dashori 20mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Dashori 20mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's unsafe. Exceptions may exist in critical medical emergencies where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Dashori 20mg tablets are incompatible; the medication poses a potential risk of infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by side effects of Dashori 20mg Tablets. Exercise caution while driving if dizziness or blurred vision occurs after taking Dashori 20mg Tablets.
KidneySAFE IF PRESCRIBED
The use of Dashori 20mg Tablet in patients with kidney disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, Dashori 20mg tablets are considered safe, and no dosage alteration is necessary.
What if you forget to take Dashori 20mg Tablet :
Omit any missed Dashori 20mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Dashori 20mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | TKIs |
